User talk:Dr.Peter kadamandla

Dr.Peter Kadamandla
Dr.Peter Founder and CEO of Urban Medical Group of Companies (UMGC) in which they are providing Urban Medical Academy and Urban Pharmaceuticals. holds a graduate degree in Doctorate of Pharmacy from JNTU-Hyderabad India. He also completed his Diploma course in Clinical Research, Pharmacovigilance, Regulatory Affairs and Medical Writing and Clinical SAS.

He is Having hands on experience in the human clinical trials. He started his career with Vigilare biopharma as a Drug safety associate in 2017.

Later in 2021 he got an contract opportunity to work with Indian Council of Medical Research (ICMR) as a Medical officer for Phase3 trails on Tuberculosis at Mediciti hospitals in Association with Bhagwan Mahaveer Medical Research Centre-BMMRC

He will follow USFDA, CDSCO, EMA, RoW and LATAM Guidelines and trails SOP, Protocols and performed the trials without any deviations. Peter have experience in the Patient counselling, Hiring of the healthy Subjects, Screening, monitoring and internal auditing for the TB trails. Handling of the ADR, ADE is the most challenging part of the job as a Medical officer (MO).

As experienced in the ICMR trials. Peter with his team will give perform with 100% accuracy to complete any trial related activities within given timelines.

Currently he is working as Snr Regulatory affairs Specialist. Working with EMA & ROW market of the Pharmaceutical products. Experiencing the Trackwise and VEEVA VAULT RIMSRegulatory information Management systems. Authorizing the Module 1, 2 & 3 documents.

Also associated with data remediation with all the MAH, including MRP-DCP, EU and ROW countries. Creating Child Action items, Closing and Updating of the Parent ReCoRD. As per the project delivery. Dr.Peter kadamandla (talk) 09:23, 23 May 2023 (UTC)

Your submission at Articles for creation: sandbox (May 23)
 Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reasons left by Eagleash were:

The comment the reviewer left was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.


 * If you would like to continue working on the submission, go to User:Dr.Peter kadamandla/sandbox and click on the "Edit" tab at the top of the window.
 * If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk/New_question&withJS=MediaWiki:AFCHD-wizard.js&page=User:Dr.Peter_kadamandla/sandbox Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:Eagleash&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=User:Dr.Peter_kadamandla/sandbox reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

Eagleash (talk) 10:09, 23 May 2023 (UTC)

Concern regarding User:Dr.Peter kadamandla/sandbox
Hello, Dr.Peter kadamandla. This is a bot-delivered message letting you know that User:Dr.Peter kadamandla/sandbox, a page you created, has not been edited in at least 5 months. Drafts that have not been edited for six months may be deleted, so if you wish to retain the page, please edit it again&#32;or request that it be moved to your userspace.

If the page has already been deleted, you can request it be undeleted so you can continue working on it.

Thank you for your submission to Wikipedia. FireflyBot (talk) 11:02, 23 October 2023 (UTC)

Managing a conflict of interest
Hello, Dr.Peter kadamandla. We welcome your contributions, but if you have an external relationship with the people, places or things you have written about on Wikipedia, you may have a conflict of interest (COI). Editors with a conflict of interest may be unduly influenced by their connection to the topic. See the conflict of interest guideline and FAQ for organizations for more information. We ask that you:


 * avoid editing or creating articles about yourself, your family, friends, colleagues, company, organization, clients, or competitors;
 * propose changes on the talk pages of affected articles (you can use the edit COI template);
 * disclose your conflict of interest when discussing affected articles (see );
 * avoid linking to your organization's website in other articles (see );
 * do your best to comply with Wikipedia's content policies.

In addition, you are required by the Wikimedia Foundation's terms of use to disclose your employer, client, and affiliation with respect to any contribution which forms all or part of work for which you receive, or expect to receive, compensation. See Paid-contribution disclosure.

Also, editing for the purpose of advertising, publicising, or promoting anyone or anything is not permitted. Thank you. Liz Read! Talk! 03:42, 23 November 2023 (UTC)